Alkem Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories has informed the stock exchanges that three of its Independent Directors — Mr. Arun Kumar Purwar, Ms. Sudha Ravi, and Ms. Sangeeta Singh — will retire from the Board effective close of business on 12th July 2025. All three are completing their second consecutive term as Independent Directors, after which they will step down. The company has disclosed the details as required under SEBI's Listing Regulations, including their DIN numbers, reason for change (retirement on term completion), and the cessation date.
This is a routine, pre-scheduled board change with no negative governance implication. However, the simultaneous exit of three Independent Directors means the company will need to appoint new Independent Directors to maintain the required board composition, which investors should watch for in upcoming filings.